Abstract Objective To investigate the characteristics and associations of MRI-visible perivascular spaces (PVS) with clinical progression and longitudinal cognitive decline across the Alzheimer’s disease spectrum. Methods We included 1429 participants (641 [44.86%] female) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. PVS number and grade in the centrum semiovale (CSO-PVS), basal ganglia (BG-PVS), and hippocampus (HP-PVS) were compared among the control (CN), mild cognitive impairment (MCI), and Alzheimer’s disease (AD) groups. PVS were tested as predictors of diagnostic progression (i.e., CN to MCI/AD or MCI to AD) and longitudinal changes in the 13-item Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-...
OBJECTIVE: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...
Abstract: Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the ...
Background: Magnetic resonance imaging‐visible perivascular spaces (PVS) are related to interstitial...
Background and objectivesPerivascular spaces (PVS) visible on magnetic resonance imaging (MRI) scans...
OBJECTIVE: To investigate the relationship between enlarged perivascular spaces (EPVS) and measures ...
Background and purpose: The association of perivascular spaces in the centrum semiovale with amyloid...
Objective: To determine if severe perivascular space (PVS) dilation is associated with longitudinal...
AbstractIntroductionWe aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signat...
MRI-visible perivascular spaces (PVS) in the semioval centre are associated with cerebral amyloid an...
Background: Perivascular spaces (PVS) have an important role in the elimination of metabolic waste f...
Background MRI-visible perivascular spaces (PVS) are potential neuroimaging markers of cerebral smal...
BACKGROUND: Growing evidence suggests an association between imaging biomarkers of small vessel di...
Perivascular spaces that are visible on magnetic resonance imaging (MRI) are a neuroimaging marker o...
Background: Perivascular spaces (PVS) have an important role in the elimination of metabolic waste f...
OBJECTIVE: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...
Abstract: Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the ...
Background: Magnetic resonance imaging‐visible perivascular spaces (PVS) are related to interstitial...
Background and objectivesPerivascular spaces (PVS) visible on magnetic resonance imaging (MRI) scans...
OBJECTIVE: To investigate the relationship between enlarged perivascular spaces (EPVS) and measures ...
Background and purpose: The association of perivascular spaces in the centrum semiovale with amyloid...
Objective: To determine if severe perivascular space (PVS) dilation is associated with longitudinal...
AbstractIntroductionWe aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signat...
MRI-visible perivascular spaces (PVS) in the semioval centre are associated with cerebral amyloid an...
Background: Perivascular spaces (PVS) have an important role in the elimination of metabolic waste f...
Background MRI-visible perivascular spaces (PVS) are potential neuroimaging markers of cerebral smal...
BACKGROUND: Growing evidence suggests an association between imaging biomarkers of small vessel di...
Perivascular spaces that are visible on magnetic resonance imaging (MRI) are a neuroimaging marker o...
Background: Perivascular spaces (PVS) have an important role in the elimination of metabolic waste f...
OBJECTIVE: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...
Abstract: Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the ...